Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Terri Pasquine"'
Autor:
Paul J Gomes, Cullen T. Vogelson, Mark B. Abelson, David T. Wells, Stella M. Robertson, F. Darell Turner, Terri Pasquine
Publikováno v:
Current Medical Research and Opinion. 21:683-691
A new formulation of olopatadine hydrochloride ophthalmic solution (olopatadine 0.2%) was evaluated in two separate, randomized, placebo-controlled, double-masked, hybrid environmental studies intended to determine efficacy and safety in subjects wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baa2b95566dbbbdaf4e53164b49edf25
https://doi.org/10.1185/030079905x43622
https://doi.org/10.1185/030079905x43622
Autor:
Stella M. Robertson, Robert D. Gross, Mark B. Abelson, Michael R. Edwards, Terri Pasquine, Paul J Gomes
Publikováno v:
Allergy and asthma proceedings. 28(4)
Olopatadine hydrochloride ophthalmic solution 0.2% (Pataday, Alcon) is a new formulation of olopatadine hydrochloride ophthalmic solution, the first topical ocular antiallergic agent indicated for once-daily dosing. The aim of this study was to evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d5fb37bf4e129f29bce6d3a012a9286
https://pubmed.ncbi.nlm.nih.gov/17883910
https://pubmed.ncbi.nlm.nih.gov/17883910
Autor:
David T. Wells, Mark B. Abelson, Cullen T. Vogelson, Stella M. Robertson, F. Darell Turner, Terri Pasquine, Paul J Gomes, M.V. W. Bergamini, Robert D. Gross
Publikováno v:
Clinical therapeutics. 26(8)
Previous studies have suggested that olopatadine hydrochloride ophthalmic solution 0.2% administered once daily is effective for up to 24 hours after instillation and is well tolerated in adults and children agedor =3 years.The goal of this study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eee6a93816ed0a39e8e9ff7e675f4e24
https://pubmed.ncbi.nlm.nih.gov/15476905
https://pubmed.ncbi.nlm.nih.gov/15476905
Autor:
Cullen T, Vogelson, Mark B, Abelson, Terri, Pasquine, Donna M, Stephens, Daniel A, Gamache, Robert D, Gross, Stella M, Robertson, John M, Yanni
Publikováno v:
Allergy and asthma proceedings. 25(1)
Pharmacologic studies examined the potential of a solution containing olopatadine to maintain and extend antiallergic efficacy after single topical ocular drop administration over 24 hours. Results of these preclinical experiments conducted in guinea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7b09412b9dc1c68ab2acce795b4d7e90
https://pubmed.ncbi.nlm.nih.gov/15055565
https://pubmed.ncbi.nlm.nih.gov/15055565